Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2024-12-28T07:25:13.413Z Has data issue: false hasContentIssue false

Voice in T1b glottic tumours, intratympanic steroids for salvage in sensorineural hearing loss, intranasal steroids for obstructive sleep apnoea and a new procedure for post-radiation nasal stenosis

Published online by Cambridge University Press:  05 April 2017

Rights & Permissions [Opens in a new window]

Abstract

Type
Editorial
Copyright
Copyright © JLO (1984) Limited 2017 

Intratympanic drug injection is now a valid alternative to systemic administration and is being widely used for an increasing number of inner-ear disorders. Its importance was highlighted in a recent article published in The Lancet, which compared the outcome of two drugs administrated intratympanically for Ménière's disease.Reference Patel, Agarwal, Arshad, Hariri, Rea and Seemungal 1

Intratympanic steroid administration has also been used as a first-line therapy for sudden sensorineural hearing loss,Reference Dallan, Fortunato, Casani, Panicucci, Berrettini and Lenzi 2 sudden infective sensorineural hearing lossReference Heywood, Ifeacho and Narula 3 and now as a salvage treatment for profound idiopathic sudden sensorineural hearing loss.Reference Dai, Lu, Hou, Yang, Li and Yang 4 This paper by Dai et al. reports on patients with sudden sensorineural hearing loss in whom conventional treatment had failed.Reference Dai, Lu, Hou, Yang, Li and Yang 4

The management of nasal stenosis that may follow chemoradiation for nasopharyngeal carcinoma has long been a problem. Apart from patients’ distress associated with this condition, the monitoring of any tumour recurrence may become less obvious. Wilmot and Hathorn describe their endoscopic technique for this difficult condition.Reference Wilmot and Hathorn 5 Their method holds promise, and may avoid the use of nasal stents and auricular grafts.Reference Raghavan and Jones 6 The procedure can be conducted as a day case.

Voice is not always the first consideration in the treatment outcomes for tumour (T) stage T1b glottic cancer, and radiotherapy is widely used. In a useful paper with substantial long-term results, Song et al. evaluated the oncological and voice outcomes of transoral laser microsurgery for T1b glottic cancer patients.Reference Song, Rigby, Trites, Hart and Taylor 7 The study revealed relatively high rates of oncological control and acceptable voice outcomes, showing its utility as a primary treatment modality for T1b glottic cancer.

Management of upper airway obstruction in Pierre Robin sequence has at times required a tracheostomy over glossopexy.Reference Bath and Bull 8 In this issue of The Journal of Laryngology & Otology, Camacho and colleagues show that tongue-lip adhesion and tongue repositioning can improve apnoea-hypopnoea index and oxygenation parameters in affected children.Reference Camacho, Noller, Zaghi, Reckley, Fernandez-Salvador and Ho 9

Intranasal steroids, by their anti-inflammatory effect of reducing cellular proliferation and the production of pro-inflammatory cytokines, may lead to a reduction in upper airway resistance, which would be of benefit in the management of obstructive sleep apnoea associated with adenotonsillar hypertrophy. This suggestion has been reviewed by Sakarya el al.Reference Sakarya, Bayar Muluk, Sakalar, Senturk, Aricigil and Bafaqeeh 10 They report a decrease in the number of children requiring surgery for adenotonsillar hypertrophy.

References

1 Patel, M, Agarwal, K, Arshad, Q, Hariri, M, Rea, P, Seemungal, BM et al. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial. Lancet 2016;388:2753–62CrossRefGoogle ScholarPubMed
2 Dallan, J, Fortunato, S, Casani, AP, Panicucci, E, Berrettini, S, Lenzi, R et al. Intratympanic methylprednisolone as first-line therapy in sudden sensorineural hearing loss: preliminary results from a case-control series. J Laryngol Otol 2011;125:1004–8CrossRefGoogle ScholarPubMed
3 Heywood, RL, Ifeacho, SN, Narula, AA. Effect of intratympanic steroid administration on sensorineural hearing loss associated with acute otitis media. J Laryngol Otol 2016;130:532–5CrossRefGoogle ScholarPubMed
4 Dai, Y, Lu, L, Hou, J, Yang, X, Li, H, Yang, Y et al. Intratympanic methylprednisolone perfusion as a salvage treatment for profound idiopathic sudden sensorineural hearing loss. J Laryngol Otol 2017;131:404–10CrossRefGoogle ScholarPubMed
5 Wilmot, VV, Hathorn, I. Surgical management of nasal stenosis following chemoradiation for nasopharyngeal carcinoma. J Laryngol Otol 2017;131:429–32CrossRefGoogle ScholarPubMed
6 Raghavan, U, Jones, NS. Use of the auricular composite graft in nasal reconstruction. J Laryngol Otol. 2001;115:885–93CrossRefGoogle ScholarPubMed
7 Song, JS, Rigby, MH, Trites, J, Hart, RD, Taylor, SM. Outcomes of transoral laser microsurgical management of T1b glottic cancer. J Laryngol Otol 2017;131:433–41CrossRefGoogle Scholar
8 Bath, AP, Bull, PD. Management of upper airway obstruction in Pierre Robin sequence. J Laryngol Otol 1997;111:1155–7CrossRefGoogle ScholarPubMed
9 Camacho, M, Noller, MW, Zaghi, S, Reckley, LK, Fernandez-Salvador, C, Ho, E et al. Tongue-lip adhesion and tongue repositioning for obstructive sleep apnoea in Pierre Robin sequence: a systematic review and meta-analysis. J Laryngol Otol 2017;131:378–83CrossRefGoogle ScholarPubMed
10 Sakarya, EU, Bayar Muluk, N, Sakalar, EG, Senturk, M, Aricigil, M, Bafaqeeh, SA et al. Use of intranasal corticosteroids in adenotonsillar hypertrophy. J Laryngol Otol 2017;131:384–90CrossRefGoogle ScholarPubMed